Evidence map›Paper›PMID 33228757›Full record

ArticleTrials2020

Optimizing the efficiency and implementation of cash transfers to improve adherence to antiretroviral therapy: study protocol for a cluster randomized controlled trial.

Laura Packel, Prosper Njau, Carolyn Fahey, Angela Ramadhani, William H Dow, Nicholas P Jewell, Sandra McCoy

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04201353 (Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy, Phase II), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04201353 nacompletednot on this map

Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy, Phase II: Effectiveness Study

TypeinterventionalSponsorUniversity of California, BerkeleyRan2020 to 2024Enrolled1,984ConditionsHIV (Human Immunodeficiency Virus)ArmsConditional Cash Transfer
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura PackelSchool of Public Health, Division of Epidemiology, University of California, Berkeley, 2121 Berkeley Way, 5th Floor, Berkeley, CA, 94720, USA. lpackel@berkeley.edu.ORCID http://orcid.org/0000-0002-8186-5246
Prosper NjauStrategic Information and Research Unit, National AIDS Control Program (NACP), Ministry of Health, Community Development, Gender, Elderly, and Children, Dar es Salaam, Tanzania.
Carolyn FaheySchool of Public Health, Division of Epidemiology, University of California, Berkeley, 2121 Berkeley Way, 5th Floor, Berkeley, CA, 94720, USA.
Angela RamadhaniNational AIDS Control Programme (NACP), Ministry of Health, Community Development, Gender, Elderly, and Children, Dar es Salaam, Tanzania.
William H DowSchool of Public Health, Division of Health Policy and Management, University of California, Berkeley, 2121 Berkeley Way, 5th Floor, Berkeley, CA, 94720, USA.
Nicholas P JewellDepartment of Medical Statistics, London School of Hygiene & Tropical Medicine, Keppel Street, Bloomsbury, London, WC1E 7HT, UK.
Sandra McCoySchool of Public Health, Division of Epidemiology, University of California, Berkeley, 2121 Berkeley Way, 5th Floor, Berkeley, CA, 94720, USA.

Funding

Optimizing the efficiency and implementation of cash transfers to improve adherenceto antiretroviral therapyR01MH112432 · NIMH · UNIVERSITY OF CALIFORNIA BERKELEY · PI MCCOY, SANDRA I · 2017 to 2021
$2.9M
NIMH NIH HHS R01 MH112432NIMH NIH HHS R01MH112432
6 · The paper itself

Abstract

backgroundAntiretroviral therapy (ART) for HIV, taken daily, is an effective strategy to clinically suppress the virus, providing the dual benefit of improved survival and vastly decreasing the risk of transmission. However, this highly effective intervention has not yet reached all who could benefit. Cash transfers are increasingly recognized as an effective strategy to motivate behavior change and improve HIV care and treatment outcomes, including engagement in HIV care and adherence to ART. Despite a growing evidence base and strong theoretical foundation for the cash transfer approach, key questions remain. To address these questions and begin to bridge the "know-do gap" with respect to cash transfers, our team is employing an implementation science approach to iterative development of an incentive-based intervention to promote ART uptake and adherence among people living with HIV (PLHIV) in the Lake Zone region, Tanzania.

methodsWe will conduct a type I hybrid implementation-effectiveness trial to test the effectiveness of a cash transfer intervention on the outcome of HIV viral suppression, and concurrently examine the potential for real-world implementation with a mobile health technology (mHealth) system. Specifically, our team will expand the intervention to 32 clinics and enroll 1984 PLHIV to (a) evaluate its effectiveness by conducting a cluster randomized controlled trial with clinics as the unit of randomization and 12-month viral suppression as the primary outcome and (b) evaluate the implementation challenges and successes at multiple levels (patient, provider, clinic). DISCUSSION: This trial will provide evidence not only about the real-world effectiveness of cash transfers for retention in HIV care and viral suppression, but also on the implementation challenges and successes that will facilitate or hinder wider scale-up within Tanzania and beyond.

trial registrationClinicalTrials.gov NCT04201353 . Registered on December 17, 2019.

Indexed as

Anti-HIV AgentsHIV InfectionsHumansMotivationRandomized Controlled Trials as TopicTanzaniaTreatment OutcomeAnti-HIV AgentsART adherenceCash transferCluster randomized trialHIVImplementation–effectiveness hybrid designTanzania

Identifiers

PMID33228757
PMCPMC7684892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.